Sociedad Americana de Hirudoterapia

Namibia Medicines Regulatory Council

Namibia MRC · Namibia · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Namibia's Medicines Regulatory Council — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Namibia
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Namibian Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), as amended
  • Namibian national medical device regulatory framework
  • Southern African Development Community (SADC) harmonised pharmaceutical frameworks where applicable
  • African Medicines Agency (AMA) harmonised frameworks (where applicable)

Prescriber Requirements

  • Health Professions Councils of Namibia–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Namibia MRC registration as applicable; English-language labelling. Standard cold-chain conditions, with logistical constraints typical of arid Southern African distribution.

Import/Export Rules

Namibia MRC and Directorate of Veterinary Services clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Namibian public health system and PSEMAS coverage depend on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Southern African regulatory frameworks are progressively coordinating through SADC and the African Medicines Agency (AMA); whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.